| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |